Registry for patients with kidney disease and heart issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data on patients with end-stage renal disease and related cardiovascular conditions. It aims to understand the relationship between chronic kidney disease and cardiovascular mortality, particularly focusing on how treatment approaches differ for these patients. The study will include adults aged 16 and older who are referred to the Nephrology team, and it will analyze the treatment patterns and outcomes in this high-risk population. No informed consent will be required as patients will be automatically included in the database for research purposes.

Why it matters

Who can join: the full rules

Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. No children will be included in this study. Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Nephrology team.

Inclusion Criteria:

1. Both male and female patients ≥16 years of age will be included
2. All patients will be reviewed by the Nephrology team a the RLH with renal disease.

Exclusion Criteria:

1\. Patients \<16 years will not be included in this study.

Where it's running

• Barts Health NHS Trust
  London, United Kingdom Recruiting

Study contacts

• Study coordinator: Krishnaraj Rathod, MBBS, PhD
• Email: k.s.rathod@qmul.ac.uk
• Phone: 02073777000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Investigating risk factors in patients with acute coronary syndrome undergoing a procedure

  This study is trying to find out what risk factors affect patients with acute coronary syndrome who are having a heart procedure and how these factors relate to their health outcomes over two years.

  Recruiting Jinan Central Hospital · Jinan, Shandong · NCT05719545

• Registry collecting data on patients undergoing heart artery procedures

  This study is collecting information from patients who are having heart artery procedures to see how they do during and after their treatment.

  Recruiting Federico II University · Naples · NCT05248165

• Comparing a new medication to standard treatment for preventing stomach issues in heart patients on blood thinners

  This study is testing a new medication called tegoprazan to see if it can prevent stomach problems just as well as the standard treatment for heart patients who are taking blood thinners.

  Recruiting at 36 sites Phase 4 Asan Medical Center · Anyang and 44 other locations · NCT04416581

• Registry for patients undergoing angioplasty in Korea

  This study is collecting information from patients who have had angioplasty to help understand how well the treatment works in real life.

  Recruiting Yonsei University · Seoul · NCT03908463

• Registry of patients with coronary artery issues and platelet test results

  This study collects information from patients with coronary artery disease to see how well their blood-thinning medications work and to find the best treatment options for them.

  Recruiting Action, France · Paris · NCT02762162

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.